Fatigue News and Research

RSS

Novel device for mitral valve repair shows success in human study

Researchers investigating a novel device to repair the mitral heart valve report 100 percent procedural success in a safety and performance study, the first such study done in humans.

19 Jul 2016

Moderate strain to muscles, nerves can provoke CFS symptoms

A recent study conducted by researchers at the University of Alabama at Birmingham and Johns Hopkins University School of Medicine published in PLOS ONE shows that symptoms of chronic fatigue syndrome, a complex and disabling multisystem disorder, can be provoked by imposing a mild to moderate strain to the muscles and nerves.

19 Jul 2016

SLU researchers study investigational vaccine for yellow fever

Saint Louis University's Center for Vaccine Development is studying an investigational vaccine for yellow fever, a potentially deadly disease that is spread by the same mosquito that transmits Zika virus.

19 Jul 2016

Novel method of mindfulness meditation can improve emotional and cognitive performance

Meditation has long been promoted as a way to feel more at peace. But research from a Texas Tech University faculty member shows it can significantly improve attention, working memory, creativity, immune function, emotional regulation, self-control, cognitive and school performance and healthy habits while reducing stress.

18 Jul 2016

New study shows patient’s self-rated health can be better predictor of illness and death

Patients' self-rated health is a better long-term predictor of illness and death than standard blood tests, blood pressure measurements or other symptomatic evidence a doctor might gather, according to a new study from Rice University.

15 Jul 2016

Combination approach could be more effective to treat fibromyalgia pain

Queen's University researcher Ian Gilron has uncovered a more effective way of treating fibromyalgia, a medical condition characterized by chronic widespread pain typically accompanied by fatigue, as well as sleep, mood and memory problems.

14 Jul 2016

Selfish mutant mtDNA exploits cellular defenses to cause many diseases

Mitochondrial disorders are a chameleon-like set of diseases that take many different forms and vary widely from individual to individual.

12 Jul 2016

Lifting lighter weights many times can be effective alternative way to gain muscle strength

New research from McMaster University is challenging traditional workout wisdom, suggesting that lifting lighter weights many times is as efficient as lifting heavy weights for fewer repetitions.

12 Jul 2016

Study identifies new blood markers to accurately diagnose Gulf War Illness

Based on a study of 85 Gulf War veterans, Veterans Affairs researchers in Minneapolis have developed a tentative panel of blood markers they say can verify a diagnosis of Gulf War Illness with 90 percent accuracy.

11 Jul 2016

Moderate to vigorous physical activity linked to improved memory in breast cancer survivors

Moderate-to-vigorous physical activity is related to improved subjective memory in breast cancer survivors, who often complain about memory problems, reports a new Northwestern Medicine study.

8 Jul 2016

Relaxing acupressure improves fatigue levels in breast cancer survivors

Acupressure helped reduce persistent fatigue in women who had been treated for breast cancer, a new study finds.

7 Jul 2016

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Amgen has announced that the European Commission (EC) has approved a variation to the marketing authorization for Kyprolis® (carfilzomib) to include use in combination with dexamethasone alone for adult patients with multiple myeloma who have received at least one prior therapy. The extended indication marks the second approval for Kyprolis by the EC in less than a year.

6 Jul 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

FDA approves Absorb GT1 BVS to treat coronary artery disease

The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease.

5 Jul 2016

First-line nivolumab promising in advanced NSCLC

Phase I results published in the Journal of Clinical Oncology suggest that nivolumab, either given alone or alongside platinum-based doublet chemotherapy, could have a role in the first-line treatment of advanced non-small-cell lung cancer.

5 Jul 2016

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and tolerability in patients with advanced colorectal cancer, according to phase III data presented at the European Society for Medical Oncology's 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

4 Jul 2016

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Researchers at the University of Wisconsin-Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing the virus to humans.

1 Jul 2016

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients with hepatocellular carcinoma, according to data from the phase III RESORCE trial, presented at the ESMO 18th World Congress of Gastrointestinal Cancer in Barcelona, Spain.

30 Jun 2016

Study highlights continuing problem of MSI in Gulf War veterans

Veterans of the Gulf War are more than twice as likely to have medically unexplained symptoms known as "multisymptom illness" (MSI), compared to Iraq/Afghanistan War veterans, according to an updated research review in the July Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine.

30 Jun 2016

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

The U.S. Food and Drug Administration approved Epclusa to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease).

28 Jun 2016

Fatigue News and Research

Novel device for mitral valve repair shows success in human study

Moderate strain to muscles, nerves can provoke CFS symptoms

SLU researchers study investigational vaccine for yellow fever

Novel method of mindfulness meditation can improve emotional and cognitive performance

New study shows patient’s self-rated health can be better predictor of illness and death

Combination approach could be more effective to treat fibromyalgia pain

Selfish mutant mtDNA exploits cellular defenses to cause many diseases

Lifting lighter weights many times can be effective alternative way to gain muscle strength

Study identifies new blood markers to accurately diagnose Gulf War Illness

Moderate to vigorous physical activity linked to improved memory in breast cancer survivors

Relaxing acupressure improves fatigue levels in breast cancer survivors

European Commission approves extended indication for Amgen's Kyprolis (carfilzomib) for the treatment of relapsed multiple myeloma patients

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

FDA approves Absorb GT1 BVS to treat coronary artery disease

First-line nivolumab promising in advanced NSCLC

Novel anti-interleukin 1-alpha antibody shows promise in treating advanced colorectal cancer patients

Wolbachia bacterium can prevent mosquitoes from transmitting Zika virus

Regorafenib drug improves survival rates in patients with hepatocellular carcinoma

Study highlights continuing problem of MSI in Gulf War veterans

Epclusa drug receives FDA approval for treating adult patients with chronic HCV

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News